HonCode

Go Back   HER2 Support Group Forums > Breast Cancer Meeting Highlights
Register Gallery FAQ Members List Calendar Today's Posts

Breast Cancer Meeting Highlights News fro recent ASCO and San Antonio Meetings

Reply
 
Thread Tools Display Modes
Old 12-13-2010, 03:57 PM   #1
Hopeful
Senior Member
 
Join Date: Aug 2006
Posts: 3,380
In Lab: Curcumin active against Her2 and may overcome Herceptin Resistance

Abstract:

http://www.abstracts2view.com/sabcs1...u=SABCS10L_663

Poster:

http://www.abstracts2view.com/sabcs1...hp?nu=P2-21-01

Hopeful
Hopeful is offline   Reply With Quote
Old 04-17-2011, 12:56 PM   #2
Rich66
Senior Member
 
Rich66's Avatar
 
Join Date: Feb 2008
Location: South East Wisconsin
Posts: 3,431
Re: In Lab: Curcumin active against Her2 and may overcome Herceptin Resistance

Quote:
In this preliminary study, we showed curcumin decrease the viability of various breast cancer cell lines (MCF-7, MDAMB-231, MCF-10A, BT-474 and SKBr-3(herceptin resistant, hr)). The combination of curcumin did not interfere with the action of herceptin. The herceptin sensitive BT-474 and herceptin resistant SKBr-3(hr) were all sensitive to curcumin treatment. In western blot analysis, the phosphorylation of HER-2, Akt, MAPK were reduced in BT-474 cells when treated with herceptin. In SKBr-3(hr) cells, the addition of herceptin did not downregulate the phosphorylation of HER-2, Akt, and MAPK. When treated with curcumin, the phosphorylation of HER-2, Akt, and MAPK of SKBr-3(hr) were decreased combined with the downregulation of HER-2 oncoprotein in a dose and time dependent manner.
...............................................
__________________

Mom's treatment history (link)
Rich66 is offline   Reply With Quote
Reply


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On

Forum Jump


All times are GMT -7. The time now is 03:17 PM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter